Create Account Sign In
Q&A Period of the Factor XI and the Contact System - North America/Europe Live Session
ISTH Academy. Presenters F. 07/01/20; 304518 Topic: Contact Pathway
Faculty / Presenters
Faculty / Presenters
Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

Click here to join ISTH or renew your membership.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

Trending Content 

Rebalancing Therapies for Hemophilia: Are You Ready?
Shapiro A, Croteau S, Bisson E. Feb 26, 2025
Factor XI/XIa Inhibition as a Target for Anticoagulation: The What, Why, and How
Weitz J, Gailani D, Connors J. Sep 11, 2024
Factor XI/XIa Inhibition: Ensuring Safety and Efficacy
Weitz J, Al-Lamee R, Johnston C. Nov 12, 2024
Thromboprophylaxis in Pregnant Patients
Archibald W, Middeldorp S, Casais P. Mar 5, 2025
Treating ITP: Working Together to Improve Outcomes
Cooper N, Kuter D, Gernsheimer T. Nov 15, 2024
Anticoagulation in Patients with Chronic Kidney Disease
Tham D, Swan D, Kiskaddon A. Jan 29, 2025
Anticoagulation for stroke prevention in AFib and treatment of VTE and PVT in cirrhosis
Afzal A, Carlin S, Roberts L. Oct 15, 2024
Monitoring and Reversal for Factor Xa Inhibitors
Xu Y, Montalvao S, Campello E. Oct 30, 2024
SSC on the Case: The Influence of Aging on von Willebrand Disease: Challenges and Considerations
Baker R, James P, Leebeek F, Connell N. Mar 20, 2025
Using AI to Predict or Guide Diagnosis/Treatment
Lam B, Sivapalaratnam S, Patell R. May 7, 2025

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies